End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.07 PKR | +0.32% |
|
-4.22% | +30.88% |
Jul. 05 | Citi Pharma Limited Appoints Ghulam Dastgeer as New Company Secretary | CI |
Jun. 24 | 33,749,997 Ordinary Shares of Citi Pharma Limited are subject to a Lock-Up Agreement Ending on 24-JUN-2024. | CI |
Business Summary
Number of employees: 594
Sales per Business
PKR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 9,780 | 100.0 % | 12,397 | 100.0 % | +26.76% |
Sales per region
PKR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pakistan
100.0
%
| 9,780 | 100.0 % | 12,397 | 100.0 % | +26.76% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rizwan Ahmad
CEO | Chief Executive Officer | - | 12-10-07 |
Asif Iqbal
DFI | Director of Finance/CFO | - | 19-10-31 |
Director/Board Member | - | 20-10-12 | |
Muhammad Riaz
IRO | Public Communications Contact | - | 19-12-31 |
Sales & Marketing | - | - | |
Muhammad Ishaq
AUD | Comptroller/Controller/Auditor | - | - |
Mustafa Ghulam
PRN | Corporate Officer/Principal | - | 19-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Nadeem Amjad
CHM | Chairman | - | 12-10-07 |
Rizwan Ahmad
CEO | Chief Executive Officer | - | 12-10-07 |
Saira Aslam
BRD | Director/Board Member | - | 20-10-12 |
Director/Board Member | - | 20-10-12 | |
Muhammad Naeem
BRD | Director/Board Member | - | 20-10-12 |
Farzin Khan
BRD | Director/Board Member | - | 21-08-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 228,461,200 | 103,233,511 ( 45.19 %) | 0 | 45.19 % |
Company contact information
![address Citi Pharma Limited(CPHL)](https://cdn.zonebourse.com/static/address/125137953.png)
Sector
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.88% | 25.51M | |
+61.53% | 848B | |
+38.95% | 627B | |
-3.66% | 363B | |
+15.06% | 318B | |
+9.18% | 299B | |
+5.89% | 234B | |
+16.53% | 225B | |
+15.67% | 179B | |
+2.47% | 167B |
- Stock Market
- Equities
- CPHL Stock
- Company Citi Pharma Limited